Bovine leukaemia virus (BLV) is known to be the aetiological agent of enzootic bovine lymphosarcoma. As the mechanism of tumour induction is unknown, we analysed the viral proteins expressed in cultured bovine cells of different origin, i.e. from enzootic or sporadic tumourous tissues, normal cells infected or not with BLV, and the reference FLK-BLV cells. We also investigated BLVs of different origins. As well as the previously described BLV polyproteins in FLK-BLV cells (pr70 and pr45) we have also found two additional polyproteins, p52 and p27. In these four proteins we observed the combined antigenicities of p24, p 15 and p l 2. We observed an additional polyprotein in p42, with the antigenicities of the p24 and the p 15 in cells derived from tumour tissue or infected in vitro with naturally occurring BLV isolates. None of these BLV-coded proteins, nor others with cross-reacting antigenicities, were encountered in non-BLV-producing cultured cells from enzootic or sporadic tumours. The use of autologous sera did not permit the detection of any proteins in addition to the above gag-coded and env-coded proteins. Thus, there is no evidence for the existence ofa gag-x fusion protein which could play a role in BLV-induced tumourigenicity.
INTRODUCTION
Bovine leukaemia virus (BLV) is an exogenous retrovirus aetiologically responsible for the enzootic form of bovine lymphosarcoma (Miller et al., 1969; Kawakami et al., 1970) . Although the viral genetic information is integrated into the DNA of tumour cells , this information is apparently not expressed at a detectable level in infected animals. Since it was considered that the homologous host had only limited potency to express BLV, a number of authors have investigated the permissiveness of heterologous cells. Van der Maaten & Miller (1976) succeeded in infecting foetal lamb kidney cells with in vitro derived BLV (FLK-BLV). This cell line maintained its virus-producing capacity through serial passages and it has since been widely used in laboratories. As natural BLV infection in cattle is restricted to B lymphocytes (Paul et al., 1977; Kenyon & Piper, 1977; Kettmann et al., 1978) , we established a number of cell lines of bovine lymphoid tumour origin according to a previously published procedure (Mamoun et al., 1981) . These were classified with respect to their origin, i.e. from enzootic tumours as Te, from sporadic tumours as Ts, and according to their BLV expression as V + or V-. This material made it possible to investigate naturally occurring leukaemogenic BLV isolates in their host cell environment.
The purpose of this report is to compare the BLV-related polypeptides expressed in cells of different origin infected with different BLV isolates. Initially, these polypeptides were detected by monospecific antibodies directed against BLV structural proteins. Subsequently, an attempt was made to detect their natural antibody counterpart in spontaneous lymphosarcomatous bovine sera, and to reveal the presence of additional proteins which could represent tumourrelated antigens. oligo(dT)-cellulose chromatography and subjected to glyoxal gel electrophoresis and blot hybridization also according to the same authors. BLV cDNA was prepared using poly(A)-containing RNA purified from BLV produced by FLK-BLV cells.
RESULTS

Cross-antigenicities of different BLV isolates
14C-labelled LB59Ly BLV proteins were immunoprecipitated and analysed by SDS-PAGE (Fig. 1 a) , and in a parallel experiment the same virus was 3zp-labelled and similarly analysed (Fig. t b) . tn addition to the previously described BLV proteins (gp51, gp35, p24, p15, p12 and pl0), ppl9, p14 and pp9 were also detected. No phosphorylation of the p15 was observed.
As our study was coficerned with BLVs of different origin, the cross-reactivity between sera of different animals with enzootic lymphosarcoma and purified FLK-BLV structural proteins were then investigated. The results of RIAs performed with iodinated gp5 t, p24, p 15 or p 12 are summarized in Table 1 , which shows that all tested sera possess high titres of gp51 and p24 antibodies. Additionally, most of the sera reacted weakly with p15 and p12 antigens. These results paralleled those obtained with the sera of hyperimmunized rabbits raised against the same proteins. Although it is clear that p15 and p12 are poorly immunogenic, it may be concluded from our analyses that at least the majority of the BLV isolates possess common p 15 and p12 antigenicities. Thus, antibodies reacting with a given protein of a particular BLV strain can be used to detect the same type of protein from other BLV strains.
BL V in naturally or in vitro infected bovine-cultured cells
The serological status of the animals from which the cell lines were derived is shown in Table  2 . All animals but one (2412) possessed BLV antibodies detectable by RIA p24 and/or RIA gp51. In cell lines from enzootic bovine lymphosarcomas (Te), BLV DNA was integrated and viral RNA expressed (V+). Interestingly, this was not the case for the cells obtained from lymphomatous kidneys of LB44, a case referred to us as an enzootic form. As animal 2412 lacked any characteristic of BLV infection it may be presumed to be the sporadic form. In the case of cells infected in vitro with BLV, BLV DNA as well as RNA expression was observed.
p24-related proteins in BL V producer cells of tumour origin ( Te V + )
Immunoprecipitation of protein extracts from TeV + cells (LB59Ly, 3010gg) with rabbit or bovine anti-p24 globulin revealed in every instance (Fig. 2b, c ) a major band with the electrophoretic mobility characteristic of the p24. In addition, proteins with apparent mol. wt. 70K, 52K, 45K, 42K and 27K were revealed, with the 45K protein predominating. None of these proteins resembled the BLV structural proteins described for the LB59Ly virus isolate. Despite RNA expression and very low virus production (data not shown) these proteins were not observed in 3894gg cell extracts (Fig. 2d) , presumably because their concentration was below the threshold sensitivity of the method.
p24-related proteins in non-producer cells of tumour origin ( Te V-and TsV-)
In order to find out whether one or several of these proteins were specific to bovine tumour cells, we investigated TeV-(LB44K, 2648Ly) and TsV-(2412Ly) cells. None of the above specified proteins was detected by RIP (Fig. 2g , p, f); thus, it may be assumed that these proteins are virus-coded and do not represent a tumour antigen of cellular origin nor are they associated with a defective BLV genome.
p24-related proteins in normal cells injected in vitro
The origin of the p24-related proteins was further investigated using normal cells infected in vitro with BLVs of different origin, namely BESP-3010, BESP-LB59, FLK-BLV and MOL-FLK. For BESP-3010 and BESP-LB59, the RIP of cell extracts revealed the presence of the (9) and 3010C (r) cells precipitated by normal rabbit serum 2"3 x 10" 8"0 x 10 ~ 2"3 x 10 ~-6-9 x 10 ~ * Titre expressed as the reciprocal of the dilution of the serum which bound 50}o ~ of the ~25I-labelled BLV antigen. same proteins bearing p24 antigenicities (Fig. 2j, k) . Thus, it may be concluded that p70, p52, p45, p42, p27 and p24 are coded by the viral genome.
As the virus from FLK-BLV has been extensively used as a BLV prototype, we compared the pattern of electrophoretic migration of the p24 antigenic proteins extracted from these cells with that from MOL cells infected with the same virus. Fig. 2 (l, m, o) shows that the anti-p24 globulins specifically immunoprecipitate proteins with apparent tool. wt. of 70K, 52K, 45K, 27K and 24K, In no instance, whatever the origin (ovine or bovine) of the ceils supporting the growth of this BLV isolate, was a 42K protein observed. At this point, it cannot be decided if this result is attributable to a complete absence of 42K or to an undetectable amount of this protein.
These results and the lack of precipitation of such polypeptides by anti-p24 ?-globulins from extracts of non-infected cells (Fig. 2e, n, q, r) reinforce the arguments for the viral origin of these p24-related potypeptides. Thus, our naturally occurring BLV isolates differ from the BLV prototype in their ability to express a large amount of a 42K polypeptide.
p15-related proteins
Immunoprecipitation experiments were performed on the same tissues using purified rabbit or bovine anti-pl5 ?-globulins. With TeV + cells the ?-globulins specifically immunoprecipitated the p15 and polypeptides also detected with anti-p24 y-globulin, namely 70K, 52K, 45K, 42K and 27K (Fig. 3a, b, e) . The same results were obtained with cell extracts prepared from normal cells infected in vitro with LB59Ly virus isolate (Fig. 3 e) . In contrast, none of the above described polypeptides was observed in BLV-free normal cells (Fig. 3g) , thus confirming their virus-coded nature. When FLK-BLV cell extracts were analysed under the same experimental conditions, the same proteins were detected except for the 42K (Fig. 3d, j) . The same explanation as above could justify this observation. In view of the absence of p24 reactivities in extracts from T e V -, T s V -and the low-virus-producing TeV + (3894gg) cells it was of interest to investigate expression of the p l 5; however, in no instance was a p 15 detected (Fig. 3f, h, i ).
p l 2-related proteins
Immunoprecipitation experiments with extracts from TeV + cells using purified rabbit antip 12 ~,-globulin revealed the presence of p 12 as well as the 70K, 52K, 45K and 27K polypeptides but not the 42K (compare Fig. 4b, c with 4a ). The RIP of extracts from normal cells infected in vitro with different BLV isolates (including FLK-BLV cells) were all identical (Fig. 4d, e) . It should be noted that the p12 itself is not always detectable due to its low radioactivity, in spite of the fact that the polyproteins are easily visualized. Non-BLV expressing cells, whether normal (Fig. 4g) , Ts (Fig. 4h) or Te (Fig. 4f, i) did not show p12 antigenicity.
Immunodetection of p24 and p12 antigenicities by protein blotting
As proteins precipitated from cell extracts are not necessarily of virus origin it is necessary to show that the precipitated peptides have not been co-precipitated with BLV-coded proteins. Therefore, we transferred electrophoretically separated cellular proteins to nitrocellulose paper and the polypeptides revealed by use of specific anti-p24 or anti-pl2 rabbit ~-globulin. The Cellular antigens recognized by autologous sera It was of interest to determine whether these BLV gag-related proteins or other proteins could be recognized by autologous bovine sera. In addition, the presence of env-related proteins, i.e. gp51 and gp35, was also monitored. Fig. 6(b) clearly shows that this is indeed the case for the gp51 and that a weak reaction occurs with the gp35 when using purified bovine anti-gp51 ~,-globulin. The precursor gpr72 was not detected, probably due to the short half-life and low amount of glycosylated proteins. Fig. 6(c, d) shows that in two autologous systems LB59 and 3010 only the expected gag-related proteins (i.e. p70, p52, p45, p42 and p24) and the env-related proteins (i.e. a weak band of gp51 and a strong one of gp35 shadowing the p27) can be observed. In view of the large amount of gp35 precipitated as compared to gp51, one can speculate on the accumulation of the former in cells and the presence of high levels of specific antibodies in the autologous serum.
70K (b) Bovine leukaemia virus (c) (d) (e) (a) (f) (h)
In the case of serum 3894 it can be seen (Fig. 6e ) that no proteins were specifically precipitated in 3894gg cell extracts, thus confirming that the absence of BLV-related proteins in these cells was not due to a lack of cross-reactivity. Finally, the same results were obtained (Fig.  6f, g, h) with either normal corneal cells of 3894, TsV -cells (2412) 
DISCUSSION
Our experiments were aimed initially at description of the structural proteins of a natural isolate o f B L V (LB59). The proteins gpS1, gp35, p24, ppl9, pl5, pl4, pl2, pl0 and pp9 were shown to be present. In contrast to the results of Uckert & Wunderlich 0979) with FLK-BLV virus, we found that phosphorylation was associated with ppl9 and pp9, and not with the pl5 of the LB59 virus.
The search for gag-related proteins in different cell systems, such as cultured cells derived from tumourous tissue from cattle with the enzootic or sporadic form of lymphosarcoma and normal cells infected in vitro with BLV of different origins, was possible in view of the crossantigenicities of the gag proteins (p24, pl5 and pl2).
Immunoprecipitation experiments using purified natural and rabbit anti-BLV proteins (p24, p l5 and pl2) allowed us to characterize BLV gag-related polypeptides in tumourous or normal bovine cells infected or not with different isolates of the virus.
Whenever BLV was expressed, we observed several BLV-specific polypeptides of apparent mol. wt. 70K, 52K, 45K, 42K, and 27K in cell extracts, in addition to the presence of the BLV structural proteins (p24, p l 5 and p12). The 70K and 45K polypeptides were shown to contain p24 antigenicity and, thus, may be identified as the precursors (pr70 and pr45) of the p24 structural protein described previously by Ghysdael et al. (1978) . The use of specific antibodies clearly demonstrated that these two proteins also contained the antigenicities of the BLV structural proteins p15 and p12. A new 52K tool. wt. polypeptide was observed in the same cell extracts which reacted with all three anti-p24, anti-pl 5 and anti-pl 2 antibodies.
A 42K polypeptide which contained only the antigenicities of p24 and p15 was present. Interestingly, the presence of this p42 was related to the origin of the virus isolate. Indeed, TeV+ cells contained this protein whereas ovine cells (FLK-BLV) infected with the BLV reference prototype did not. In order to determine whether the species of origin (bovine or ovine) of the cells supporting BLV gro~x, th played a role in the expression of the p42, two BLV isolates from TeV + cells and the reference prototype BLV from FLK-BLV were used to infect normal bovine cells. It was observed that the presence of the p42 was strictly associated with the virus strain. Thus, despite their cross-antigenicity, the two BLVs isolated from TeV + cells differ from the BLV reference prototype. However, this result only reflects quantitative differences. Indeed, by use of the protein blotting technique a 42K tool. wt. protein was detectable in FLK-BLV cell extracts. This could be attributable to a high processing rate of the 42K polypeptide in cells infected with this BLV strain. Such variations of the different BLVs, particularly between the French strains and the American one, recall the observations of Kettmann et al. (1981) who showed, by use of restriction endonucleases, genomic differences related to the geographic area from which the BLV strain originated. This result raised the question of whether this protein is specifically associated with potentially oncogenic BLVs or whether genetic differences in the virus strains correspond also to differences in the processing of the proteins.
The previously undescribed protein, mol. wt. 27K, was also observed in all BLV expressing systems; this polypeptide contains the three antigenicities p24, p15 and pl2. Interestingly, because of its low mol. wt. this p27 cannot be a polyprotein containing the entire sequences of p24, p15 and p12. The unexpected observation of such a protein raised the question of its real antigenicities, as it could have been a normal cellular protein that co-precipitated with BLVcoded material. Its detection with specific y-globulin, using the protein blotting technique, clearly shows its BLV-coded origin. The highly conserved presence of the p27 in all three BLV strains so far investigated is strongly suggestive of a possible biological role.
It should be emphasized that like normal cells, TeV-or TsV -cells do not contain any of the above described gag-related polypeptides nor viral polypeptides of any other type and, in particular, no polypeptides bearing only p15 or p12 antigenicities.
The results obtained either with TeV + or with normal cells infected in vitro with BLVs indicate that the same proteins were detected in each by anti-BLV structural proteins. As in normal cells no such specific precipitations occurred with cells of tumour origin, either TeV -or TsV-. No additional proteins were precipitated with the sera of autologous lymphosarcomatous animals. Based on these results we found no evidence ofa 'gag-x' fusion protein or of an 'onc' protein. This is in agreement with the results of Deschamps et al. (1981) who did not find onc sequences in the BLV genome. Noticeably, Kettmann et al. (1982) also showed that the mechanism of cell transformation by BLV cannot be attributed to 3' transcriptional promotion of downstream cellular sequences.
This raises the question of the mechanism of the leukaemogenic process induced by BLV. The search for such a mechanism should answer the question why only a very small fraction of BLVinfected cattle effectively develop lymphosarcomas. This important question is also relevant to the human ATL disease apparently induced by the newly described HTLV (Hinuma et al., 1981 ; Poiesz et al., 1980 Poiesz et al., , 1981 Kalyanaraman et al., 1982) . Indeed, this virus is competent, is the only virus which possesses a p24 structurally related to that of BLV, and the p 12s of the two viruses immunologicaUy cross-react (Oroszlan et al., 1982) . This emphasizes the need for a better knowledge of BLV cell-associated polypeptides and of their biological functions.
